LLY
Lost - 4 Days RemainingEli Lilly and Company
Recommendation Date: 10/31/2025 Update: 11/04/2025 12:38 PM (47 updates)
Trade Plan
Entry
$848.00-$865.00
Exit
$952.00-$952.00
Stop Loss
$895.00
Horizon
9d
Original Confidence
86%
Updated Confidence
86%
Score
0.910
Evidence
Price at Pick:$862.60
Prior Close:$844.50
MACD Value:15.286766
MACD Signal:14.598816
MACD Histogram:0.687951
Trend:Bullish Momentum
Support Est:$840.00
Resistance Est:$870.00
Current Quote
Price
—
Change
—
Open
—
Volume
—
Rationale
LLY is the GLP-1 giga-chad. They crushed Q3, raised the bar, and the Street basically said “front row seat to growth.” The obesity pill pipeline? They’re literally building inventory before the green light—while the competition is trimming sails. That’s not hopium; that’s a factory floor flex. We buy the dip between 848–865, then ride the gain train to 952–970. MACD’s purring, RSI’s warm (not fried), and the chart looks primed to send past old highs like they never existed.
What could nuke it? Novo throwing elbows, supply hiccups, or the macro clowns tripping the circuit breakers. That’s why we slap a hard stop at 820—no diamond hands if the thesis cracks. But right now, cash flows, guidance, and demand are vibing. This is one of those “buy the big dog after a blowout” setups. 10% in under two weeks? That’s just the appetizer if the weight-loss wave keeps rolling. Bag the shares, ignore the noise, and let Big Pharma do Big Pharma things.
Catalyst quality: Eli Lilly delivered a forceful Q3 with 54% revenue growth, guided higher for the full year, and won recent regulatory approvals, reaffirming its leadership in obesity and diabetes therapeutics. Fresh analyst commentary characterizes LLY as in the “pole position” for growth, with the pipeline and manufacturing scale to sustain momentum. This is a clear, durable, multi-quarter catalyst—beats plus raised guidance—tailored to a 6–10 day swing as institutions recalibrate forward estimates and retail follows the tape.
Fundamentals in focus: The demand surge for obesity drugs continues to reshape biopharma, and Lilly is benefiting disproportionately. The company is also investing ahead of pill approvals, building inventory and manufacturing resilience to support launches—evidence of operational readiness. Analysts highlighted strong international demand and forthcoming assets that extend the growth runway. These narratives reduce the risk of a one-off pop and lean toward follow-through as the market considers incrementally higher revenue and margin trajectories.
Technicals and setup: Price is 862.60, up from 844.50 prior close and well above short-term trend markers (EMA9 ~831 and EMA21 ~818). Momentum is constructive: MACD line (15.29) is above signal (14.60) with a positive histogram; RSI near 66 suggests strong but not exhausted. I anchor near-term support around 840 (above the EMA9 cluster) and resistance around 870 (Friday high ~869.9). The plan is to buy strength on controlled dips into 848–865, consistent with intraday volatility after a sharp reaction day.
Targets and horizon: The 9-day target band is 952–970, implying +10% to +12% from the top of the entry range. That level is modestly above the 52-week high (935.6), but given the fundamental step-up, it’s reasonable that price retests and then overshoots former highs. Earnings-driven re-ratings often travel in bursts, particularly when guidance and category momentum (GLP-1s) remain favorable.
Risk and invalidation: Key risks include (1) competitive maneuvers by Novo Nordisk or others in obesity; (2) supply constraints that cap near-term sales; and (3) macro rotations out of pharma/growth. The stop at 820 sits below the EMA cluster and recent swing structure. A decisive close below 830 with weakening MACD would argue for patience and re-entry closer to the EMA50 (~793) rather than forcing the breakout. I’d trim partials at ~940 on the way to targets to manage event risk and lock gains.
Why 10% is realistic: Multiple, corroborating signals—earnings beat, raised guidance, analyst reinforcement, and strong technical posture—support a continuation move. With obesity therapeutics as one of the market’s highest-conviction secular themes, LLY is positioned for incremental price discovery above prior highs. The risk/reward into a 9-day window, using 820 as a fail-safe, remains attractive.
Updates
11/04/2025 12:38 PM
Tighten Stop
Stop Loss: 895
RSI_overbought
extended_above_short_term_EMAs
overhead_resistance_near_prior_highs
momentum_reversion_risk
LLY remains on-track post-earnings with strong momentum (MACD rising, RSI elevated). Price (~905) is well above entry band and below the 952–970 target zone; no target/stop/horizon rules triggered. Given overbought conditions and extension above short MAs, tighten risk to protect gains. Maintain original target band; consider trimming a portion into 935–945 (near prior highs) while riding remainder toward 952–970 if momentum persists.
Confidence 86%
11/04/2025 11:39 AM
Tighten Stop
Stop Loss: 892
overbought_RSI
breakout_failure_risk
gap_fill_risk
elevated_social_attention_volatility
post-earnings_momentum_fade
LLY remains on post-earnings momentum: price ~905 is well above short-term MAs with bullish MACD, though RSI ~74 is stretched. No target or stop levels have been triggered and horizon remains open. To manage risk into overbought conditions and rising attention, tighten the stop to protect gains while keeping the original targets intact. Expect chop/pullbacks; consider opportunistic trims into the 935–940 zone ahead of the official target band if momentum stalls.
Confidence 85%
11/04/2025 10:38 AM
Tighten Stop
Stop Loss: 890
RSI_overbought
momentum_extended
profit_taking_near_prior_highs
gap_fill_risk
macro_rotation_risk
elevated_social_buzz_volatility
LLY remains in a strong post-earnings momentum trend: last 911.34 with bullish MACD and RSI ~73. Targets (952–970) not reached and horizon still open (expires 2025-11-09). No adverse news; sentiment is elevated. Given overbought readings and a fast move, tighten risk to protect gains while allowing some wiggle. Note: original write-up mentioned a deeper fail-safe (~820), but the active record stop has been managed higher; continuing with a tighter trailing stop to lock profit. Consider trimming into 940–945 if momentum stalls en route to targets.
Confidence 86%
11/04/2025 09:41 AM
Tighten Stop
Stop Loss: 875
rsi_overbought_70plus
elevated_volatility_from_social_buzz
gap_risk_vs_prior_close
Momentum and trend remain strong: price holds well above EMA9/21 with bullish MACD and rising social interest. No target hit and not at horizon. RSI >70 signals overbought/heat, so protect gains. Keep the 952–970 target band and 9-day window into Nov 9. Tightening the stop to lock profit in case of a momentum fade.
Confidence 88%
11/04/2025 08:36 AM
Hold
RSI_overbought_>70
EarlyHours_liquidity_gap_risk
Potential_gap_fill_to_880-870
Resistance_near_prior_highs_930-950
Tight_stop_vs_support_may_whipsaw
LLY is trending well post-earnings: price ~896 with bullish MACD and RSI ~73. Targets (952–970) not hit and horizon (through 2025-11-09) remains. No adverse news; social interest up. Overbought conditions raise pullback risk, but trend intact. Maintain plan toward 952–970; consider taking partials into 930–940 to de-risk. Current stop (872) is tight relative to new support near 870; be aware of potential whipsaw on a standard retest. No rule-based exit triggered.
Confidence 89%
11/04/2025 07:37 AM
Tighten Stop
Stop Loss: 872
RSI_overbought_70plus
breakout_retest_risk_around_870
early_hours_liquidity_slippage
gap_fill_pullback_risk
LLY is tracking well above the 848–865 entry window at 896.35 with strong momentum (bullish MACD, RSI ~73). No target hit (952–970) and not near horizon expiry (Nov 9). Given the breakout over the ~870 area and elevated RSI, protect gains by tightening the stop to just below the new support. Keeping targets and horizon unchanged. Note: original text referenced a deeper fail-safe (~820) while the structured stop showed 870; using a tightened trailing stop now that price has cleared resistance.
Confidence 88%
11/04/2025 06:36 AM
Tighten Stop
Stop Loss: 870
RSI_overbought
extended_above_EMA
gap_fill_risk
competitor_event_risk
LLY remains on track: price is 896.35, well above the 848 stop and below the 952–970 target band. Momentum is strong (bullish MACD, RSI >70), and news flow is supportive with rising social interest. No stop/target/horizon rules triggered. Given the breakout above prior resistance (~870) and extended distance from the original stop, tighten risk to protect gains; allow for a normal pullback without round-tripping the win. Consider taking partials into 935–945 if offered while keeping core for the 952–970 target. Use regular-hours stops to avoid premarket illiquidity wicks.
Confidence 90%
11/03/2025 20:35 PM
Tighten Stop
Stop Loss: 848
RSI_overbought_70plus
momentum_cooldown_risk
approaching_prior_high_resistance
sector_rotation_risk
supply_constraint_headline_risk
LLY is following through post-earnings with strong momentum (MACD rising, RSI ~73) and supportive news/buzz. Price remains below the 952–970 target band and far above the stop; horizon not yet reached. Given the overbought reading and rapid extension from short-term averages, tighten risk slightly while keeping the original target band and horizon. Expect digestion/pullbacks; protect gains without choking normal volatility.
Confidence 89%
11/03/2025 19:35 PM
Tighten Stop
Stop Loss: 842
RSI_overbought_70plus
gap_risk_next_open
extended_above_EMA9
approaching_prior_highs
social_sentiment_spike
Momentum follow-through post-earnings remains strong (RSI >70, bullish MACD) with supportive news flow and rising social interest. No stop or target triggers; horizon intact (through Nov 9). Given elevated RSI and distance from short-term averages, tighten risk to protect gains while keeping the upside band unchanged. If price pushes into 940–945 ahead of targets, consider trimming a portion to manage overbought risk; otherwise ride momentum toward 952–970.
Confidence 88%
11/03/2025 18:36 PM
Tighten Stop
Stop Loss: 875
RSI_overbought
near_52w_high_resistance
after_hours_liquidity
momentum_extension
LLY continues to follow through on the earnings beat: price 896.35 (AH), MACD rising with positive histogram and RSI ~72.7. News flow and social interest are supportive, and no stop/target/horizon rules have triggered. With the tape extended and resistance likely near the prior highs (~935–940) ahead of our 952–970 target band, we will tighten the stop to protect gains while keeping targets and horizon intact. Consider opportunistic trims into the 940 area per plan, but official targets remain unchanged.
Confidence 86%
11/03/2025 17:36 PM
Tighten Stop
Stop Loss: 872
RSI_overbought
extended_from_short_MAs
after_hours_liquidity
gap_fill_risk
sector_rotation_risk
Still within the 9-day window (day 3) with strong post-earnings follow-through. Price ~896 is well above EMA9/21 and prior resistance near 870; MACD remains bullish and RSI ~73 shows strong momentum but edging into overbought, increasing pullback risk. No stop or target has triggered. To protect gains and account for elevated momentum/after-hours liquidity, raise the stop just above the 870 breakout area. Keep targets intact given the fundamental tailwind and trend strength. Note: original narrative referenced an 820 fail-safe, while the structured plan listed 868; aligning with the structured level and tightening to trail support.
Confidence 88%
11/03/2025 16:36 PM
Hold
rsi_overbought_70plus
extended_above_ema
after_hours_liquidity
breakout_retest_risk_870
plan_stop_inconsistency_noted
ACTIVE. Price (896.35) is well above entry zone (848–865), the stop (868) has not been breached, and the 9-day horizon from 2025-10-31 has not expired. Momentum remains strong (bullish MACD, RSI ~73), aided by positive news flow and rising social interest. However, RSI >70 and the extension above short-term EMAs increase pullback/retest risk toward the 870 breakout area. Targets (952–970) remain unhit. Note: the narrative mentioned a 820 stop, but the plan’s explicit stop_loss is 868; using the explicit plan level as authoritative. Consider taking partials into strength as price approaches the prior high region (~930–940) on the way to targets to manage overbought risk.
Confidence 87%
11/03/2025 15:35 PM
Hold
rsi_overbought
momentum_extension
gap_extension
target_below_all_time_high_zone
LLY is extending its post-earnings momentum: last 895.44 with bullish MACD and rising EMAs. RSI ~72 signals near-term overbought, so expect chop/pullbacks but no technical breakdown; price remains well above support and below the 952–970 target band. No stop breach and horizon (9 days from 2025-10-31) not yet expired. Maintain the trade, avoid chasing adds at these stretched levels; prefer adds only on controlled dips if they occur. Note: the plan text mentioned an 820 fail-safe, while the structured stop shows 868; managing to 868 (more protective). Either way, no breach. Consider harvesting small partials into the low-940s if reached en route to targets to reduce volatility risk.
Confidence 88%
11/03/2025 14:36 PM
Hold
RSI_overbought
breakout_retest_risk
macro_rotation_risk
headline_competition_risk
LLY is following through post-earnings with strong momentum (price ~899.68, bullish MACD, RSI ~73). No stop, target, or horizon triggers have occurred. Maintain the trade as ACTIVE. Keep the operational stop near 868 (just below the ~870 breakout area) to protect gains if the breakout fails. Targets remain 952–970 within the 9‑day window; be prepared to trim on strength into the low-940s per plan. RSI is elevated, so a retest of 870 is possible—avoid chasing adds; hold core and let the trend work.
Confidence 90%
11/03/2025 13:36 PM
Hold
rsi_overbought_70_plus
extended_above_short_term_emas
approaching_prior_high_resistance
macro_rotation_risk
competition_glp1_category
potential_supply_constraints
momentum_could_mean_reversion_short_term
LLY is progressing well post-earnings with price at 891.69, strong bullish momentum (MACD > signal, positive histogram) and RSI ~72 indicating strength but near-term overbought risk. Social mentions are rising and recent headlines remain supportive. We have not reached targets (952–970) and the 9-day window (day 3 of 9) is intact. Keep the defined stop at 868, which sits just below the prior breakout/pivot region (~870), and respect partial profit-taking into strength near the low-940s en route to targets to manage overbought risk. Expect digestion/pullbacks after the run; avoid chasing and let the trend work while protecting gains with the existing stop.
Confidence 88%
11/03/2025 12:36 PM
Tighten Stop
Stop Loss: 868
rsi_overbought
extended_from_ema
breakout_retest_risk
macro_rotation_risk
competition_headlines_risk
LLY remains on track: last ~890.9 is well above entry (848–865) and below the 952–970 target band. No stop or horizon rules triggered. Momentum is strong (bullish MACD), but RSI ~72 signals near-term stretch and potential for a pullback or breakout retest. To protect gains after the 870 breakout, tighten the stop just below that pivot. Keep targets and horizon unchanged; consider opportunistic trims on sharp extensions toward the low-940s while aiming for the 952–970 band.
Confidence 86%
11/03/2025 11:36 AM
Tighten Stop
Stop Loss: 862
RSI_overbought
extended_from_ema
breakout_continuation
macro_rotation_risk
competitive_headline_risk
supply_constraint_risk
LLY is following through post-earnings: price ~885 is above the 9/21EMAs, MACD is positive and rising, and RSI ~71 shows strong momentum (slightly overbought). Breakout over the 870 area is holding intraday. No stop or target has been triggered and horizon (9 days from 2025-10-31) remains open. Maintain the target band 952–970; tighten risk to protect gains if the breakout fails. Consider trimming near prior highs (~935–940) on the way to targets to manage volatility.
Confidence 88%
11/03/2025 10:36 AM
Hold
RSI_near_overbought
price_extended_above_EMA9
overhead_resistance_near_prior_high_935
stop_above_near_term_support_may_whipsaw
market_still_within_horizon_window
Price is advancing post-earnings (last ~876.5 vs prior close ~862.9) with bullish momentum (MACD > signal) and RSI near 70. Neither target (952–970) nor stop (850) has been touched, and the 9-day horizon (thru ~Nov 9) remains. Maintain ACTIVE, keep current levels. Note: original text referenced a 820 stop; managing to the explicit plan stop_loss of 850. If momentum stalls near the prior high (~935), consider partial trims, but core targets unchanged.
Confidence 90%
11/03/2025 09:35 AM
Tighten Stop
Stop Loss: 850
rsi_elevated_near_overbought
momentum_extended_above_ema9_ema21
approaching_prior_high_resistance_~935
gap_follow_through_risk_if_momentum_fades
Price 877.34 is well above the 848–865 entry band and far from the 845 stop. Momentum remains constructive (RSI ~66.7, MACD > signal, positive histogram) with price riding above short-term EMAs. No stop/target/horizon triggers. Given the extension versus EMAs, tighten risk: raise the stop to 850 (just above the lower prior entry region) to reduce drawdown while allowing normal volatility. Keep the 952–970 target band and the 9-day horizon intact. If strength continues into the 930s near the prior high (~935), consider discretionary partial trims to de-risk on the way to targets; avoid adding above 875–880 and look for controlled dips if adding is necessary.
Confidence 89%
11/03/2025 08:35 AM
Hold
pre-breakout-resistance-near-prior-highs
sector-rotation/macro-risk
competitor-headline-risk (GLP-1 space)
early-hours gap/volatility risk
Setup remains on-track. Price holds well within the 848–865 buy zone and above rising EMAs with bullish MACD and RSI ~67, and news flow is supportive. No stop/target/horizon rules triggered. Maintain the operative stop at 845 per the structured plan (ignore the 820 mention in narrative as a mismatch). Prefer buying controlled dips in-range; consider trimming a slice near ~940 on approach to prior highs to manage headline/macro risk while targeting 952–970 within the 9-day window.
Confidence 88%
11/03/2025 07:34 AM
Tighten Stop
Stop Loss: 845
pre_market_liquidity_thin
approaching_prior_highs_resistance
elevated_rsi
gap_risk_open
sector_rotation_risk
Position remains valid: price (862.6) sits within the defined entry band (848–865), well above EMA9/21 with bullish MACD and RSI ~67 indicating strong but not extreme momentum. No stop/target/horizon triggers: stop 840 not breached, targets 952–970 not reached, horizon (9 days from 2025-10-31) still open. News flow remains supportive of the growth thesis in GLP-1s. Given sustained strength and to manage gap/volatility risk into the open, tighten the stop modestly below recent support. Maintain target band; consider planned partials on strength per original plan.
Confidence 87%
11/03/2025 06:34 AM
Hold
early_hours_liquidity
overhead_resistance_around_870
target_requires_new_highs
post_earnings_volatility
Thesis remains intact. Price (862.6) is within the planned entry band and well above key EMAs (9/21), with bullish MACD and RSI ~67. No stop (840) breach, no target (952–970) hit, and horizon (9 days from 2025-10-31) not reached. Overhead resistance near ~870 remains the first test; a sustained break improves odds of a retest of prior highs (~935) en route to targets. Maintain the current plan and monitor 848–850 as initial support; 840 is the hard stop per the explicit plan.
Confidence 86%
11/02/2025 20:34 PM
Hold
overhead_resistance_near_870
gap_risk_on_reopen
post_earnings_volatility
LLY remains on plan. Price (862.6) sits within the 848–865 entry band, above EMA9/21 with bullish MACD and RSI ~67—momentum constructive into the new week. No stop/target/horizon rules triggered. Overhead supply near ~870 remains the first test; a clean break/hold above would improve odds toward the 952–970 target band within the 9-day window (expires 2025-11-09). Hard stop honored at 840 per plan fields (ignore earlier narrative reference to 820). Consider opportunistic partials near ~940 on the way to targets to de-risk, but core targets unchanged.
Confidence 86%
11/02/2025 19:34 PM
Hold
gap_risk
sector_rotation_risk
competitive_headlines_risk
supply_constraint_risk
momentum_breakdown_risk
Price (862.6) sits within the 848–865 entry band and well above the 9/21 EMAs; momentum remains constructive (RSI ~67, bullish MACD). No stop/target/horizon triggers. Maintain the current plan: hard stop 840, target band 952–970 within the 9-day window ending Nov 9. Near-term level to watch is a clean break/hold above ~870; if strength persists and a higher low forms, consider trailing the stop up on that next pullback. If momentum fades and we get a decisive close back below ~848 with MACD deterioration, reduce risk. Optional risk management: take partials into ~940 on strength ahead of the target band.
Confidence 86%
11/02/2025 18:34 PM
Hold
weekend_gap_risk
prior_high_resistance
macro_rotation_risk
competitive_headlines_GLp1
supply_constraint_headlines
LLY remains within the planned entry band with momentum intact. No stop or target triggers and horizon remains open. Technicals are supportive (price above EMA9/21, bullish MACD, RSI ~67). Maintain the explicit stop at 840 per plan fields (ignore the narrative’s 820 mention). Expect resistance near prior highs (~935–940) on the way to the 952–970 target band; consider trimming into strength there to manage risk. Watch for weekend gap risk and any GLP-1 competitive or supply headlines that could introduce volatility.
Confidence 85%
11/02/2025 17:33 PM
Hold
overhead_resistance_~870
weekend_gap_risk
gap_through_stop_risk
sector_headline_risk_GLp1/competitors
elevated_RSI_near_70
LLY remains within the defined buy zone (last 862.6 vs. 848–865). No stop or target triggers and the 9-day horizon is intact. Momentum still constructive (RSI ~67, MACD positive) with price holding above EMA9/21. Overhead resistance near 870 is the next hurdle; a clean break and hold would strengthen the path toward 900/935 on the way to the 952–970 target band. Keep the hard stop at 840 for now; consider trailing tighter only after a confirmed breakout over 870 with follow-through. Be mindful of Monday gap risk and headline sensitivity in the GLP‑1 space.
Confidence 86%
11/02/2025 16:33 PM
Hold
gap_risk_after_weekend
near_term_resistance_around_870
post_earnings_volatility
No rules triggered. Last 862.6 is above the 840 stop and below the 952–970 target band; horizon (9 days from 2025-10-31) has not expired. Momentum remains constructive (RSI ~66.7, MACD positive) with price above EMA9/21 and near planned entry range. Respect 840 as the operative stop (explicit plan parameter). Expect resistance near 870; a clean push/hold above that can open a run toward prior highs. Prefer adding on dips within the 848–865 band rather than chasing a gap. Monitor for any momentum rollover or decisive break of 840.
Confidence 87%
11/02/2025 15:34 PM
Hold
nearby_resistance_~870
gap_risk_next_open
macro_rotation_risk
competitive_headlines_in_obesity_space
supply_constraint_headline_risk
Price (862.6) remains in the planned entry band (848–865) with bullish momentum (RSI ~67, MACD positive) and no negative news flow. No stop, target, or horizon rules have been triggered. Maintain the plan: look for a push/close above ~870 to confirm continuation toward the 935–940 supply zone en route to the 952–970 target band. Be mindful of gap risk into the next session; if momentum stalls under 870 for multiple sessions, reassess. Partial profit consideration near ~940 remains prudent.
Confidence 88%
11/02/2025 09:41 AM
Hold
near_term_resistance_~870
rsi_>65_short_term_overbought_risk
monday_open_gap_risk
stop_is_tight_vs_intraday_swings
LLY remains within the planned entry zone and well above the stop. No target or stop levels have been triggered, and the 9-day horizon is intact. Momentum signals (RSI mid-60s, bullish MACD) and supportive post-earnings tone keep the long thesis intact. Near-term resistance sits around 870; watch for Monday gap risk. Maintain current plan and risk controls.
Confidence 89%
11/02/2025 08:37 AM
Hold
post-earnings volatility
gap risk (next session)
sector rotation risk
GLP-1 supply/competition headline risk
ACTIVE. Price (862.6) sits within the 848–865 entry band and above the 840 stop; no stop/target/horizon trigger. Horizon remains open through 2025-11-09. Momentum stays constructive (RSI ~66.7, bullish MACD) with price above EMA9/21. Keep plan intact: stop 840; target band 952–970. Tactically: watch 870 resistance—if a clean breakout/close above 870, consider tightening stop into 845–850 on follow-through next session; if early fade below ~850 on rising volume, avoid adds but hold unless 840 breaks. Can trim a starter around ~940 on strength per original plan. Key risks: weekend/next-session gap risk, GLP-1 supply/competition headlines, sector rotation.
Confidence 89%
11/02/2025 06:37 AM
Hold
gap risk on next open
RSI elevated (>65)
overhead supply near prior high
macro/sector rotation risk
headline risk around GLP-1/obesity theme
Last price 862.6 sits within the planned 848–865 entry band, so the position is considered initiated. No evidence of a stop-loss breach (explicit stop 840), no target touch (952–970), and horizon (9 days) has not expired (valid through 2025-11-09). Momentum remains constructive (RSI ~66.7, MACD positive). Near-term resistance around 870; a clean break should improve momentum toward the prior high zone before the target band. Maintain defined risk at 840 and follow the original 9-day plan; no changes to levels at this time.
Confidence 89%
11/01/2025 20:36 PM
Hold
approaching_prior_high_resistance
macro_rotation_risk
competitive_headlines_risk
weekend_headline_gap_risk
LLY remains above the defined stop (840) and well below targets (952–970). Momentum signals are intact (bullish MACD, RSI ~67) and news flow stays supportive. Price closed inside the planned entry zone (848–865), keeping the setup valid. No stop/target/horizon triggers and no thesis-breaking developments. Maintain the plan; consider opportunistic trims into the 940s en route to targets if strength accelerates. Monitoring next: hold >850 on dips, a clean push through ~870, and subsequent retest of prior highs near the mid-930s. Using 840 as the operative stop per the explicit plan.
Confidence 89%
11/01/2025 19:37 PM
Hold
gap_risk
overhead_resistance_870
macro_rotation_risk
competitor_headline_risk
supply_constraint_headline_risk
LLY remains within the planned entry zone and above short-term EMAs with bullish MACD and RSI not overbought. No stop/target/horizon rules triggered; position stays active. Respecting the explicit stop at 840 per plan. Key near-term level is 870 resistance—sustained break and hold would set up a run toward prior highs (~935) and the 952–970 target band. Be mindful of weekend gap and macro rotation risk; avoid adding until strength >870 confirms. Consider opportunistic trims into ~940 on strength while still targeting 952–970.
Confidence 88%
11/01/2025 18:38 PM
Hold
weekend_gap_risk
overbought_risk
resistance_near_870
overhead_supply_near_prior_high_935
macro_rotation_risk
competition_novo_risk
supply_constraints_risk
ACTIVE. Price 862.6 sits within the 848–865 entry zone, above EMA9/21 with bullish MACD and RSI ~67. No stop/target/horizon triggers (stop 840 intact; targets 952–970 not reached; horizon through 2025-11-09). Near-term resistance around 870 and the prior high zone into ~935 could cause hesitation; watch for a higher low on any pullback toward 850–855. We’ll adhere to the structured stop at 840 (ignore the narrative 820). Consider opportunistic trims near ~940 ahead of former highs and re-add on constructive retests; otherwise hold for the 952–970 band.
Confidence 89%
11/01/2025 17:37 PM
Hold
weekend_gap_risk
overhead_resistance_around_870_and_prior_high_near_935
macro_rotation_risk
competitive_headline_risk_(Novo)
supply_constraint_headline_risk
post_earnings_drift_or_gap_fill_risk
LLY remains within plan. Last price 862.6 sits inside the 848–865 entry zone; no stop-loss breach (840) and no target tag (952–970). Horizon remains open through 2025-11-09. Technicals stay constructive (RSI ~67, MACD > signal) and news tone is positive post-earnings. Maintain current levels and monitor 870 and the prior high area near 935 as resistance; a clean breakout with volume would justify tightening stops on strength next week. For now, keep the existing stop/targets unchanged to avoid whipsaw near support.
Confidence 88%
11/01/2025 16:36 PM
Hold
post_earnings_volatility
near_term_resistance_~870
RSI_elevated_but_not_overbought
macro_rotation_risk
No stop/target/horizon triggers. Last 862.6 remains within the planned 848–865 entry zone and well above the 840 stop. Momentum stays constructive (RSI ~67, bullish MACD) with no adverse news flow; earnings beat narrative intact. Operative stop is 840 per plan header (ignore the 820 mention in the long-form text). Maintain posture; look for a clean push through ~870 to confirm follow-through toward 952–970 over the 9-day window.
Confidence 88%
11/01/2025 15:37 PM
Hold
gap_down_risk
overhead_supply_near_prior_highs_935-940
sector_rotation_risk
headline_risk_competitor_actions
supply_constraint_headline_risk
weekend_event_risk
No stop/target/horizon triggers. Price (862.6) closed within the 848–865 entry band and above short-term MAs; MACD remains positive and RSI ~67 suggests strong but not overextended momentum. News flow stays supportive post-earnings. Maintain the plan toward 952–970 over the 9-day window; consider tactical trims near ~940 en route to targets. Use 840 as the operative hard stop per the plan; be mindful this is relatively tight versus EMA9 and could whipsaw on a gap—reassess intraday if market tone weakens.
Confidence 88%
11/01/2025 14:40 PM
Hold
weekend_gap_risk
overhead_resistance_870
overhead_supply_near_prior_highs
plan_inconsistency_stop_levels
macro_rotation_risk
Price closed 862.6, inside the 848–865 entry band, with bullish momentum (RSI ~67, MACD positive). No stop (840) or target (952–970) triggers and horizon (9 days from 2025-10-31; expires 2025-11-09) remains open. Maintain position; respect 870 as near-term resistance and prior-high supply into ~935–940 before target zone. Note: plan text referenced a 820 stop, but structured stop is 840—using 840 as binding risk level. If price convincingly breaks and holds above 870 next week, consider trailing risk tighter on follow-through; otherwise keep current levels.
Confidence 87%
11/01/2025 13:38 PM
Hold
gap_risk
overhead_resistance_~870
macro_rotation_risk
competition_headline_risk
supply_constraint_risk
LLY remains on-plan: price (862.6) sits within the 848–865 entry zone, momentum is constructive (RSI ~67, MACD positive), and no stop/target/horizon rule has triggered. Overhead resistance near ~870 remains the next test; above that, room opens toward prior highs and the 952–970 target band. We continue to respect the explicit stop at 840 per the trade parameters (noting the narrative reference to 820 was inconsistent). Weekend gap risk applies with the market closed; no new negatives in the provided news flow. Consider trimming near ~940 on strength en route to targets to manage event risk.
Confidence 86%
11/01/2025 12:39 PM
Hold
weekend_gap_risk
overhead_supply_near_prior_highs
peer_headline_risk
supply_constraint_risk
macro_rotation_risk
No stop/target/horizon rule triggered. Last 862.6 sits within planned entry band (848–865), well above the explicit stop 840 and below the 952–970 target zone. Momentum remains constructive (RSI ~67, MACD positive), and news tone is supportive. Maintain the plan: defend 840 as the fail-safe (note: using the explicit 840 stop from the plan parameters), watch 870 resistance; a strong break/close above could accelerate toward prior highs en route to the target band. Be mindful of weekend gap risk; if a gap-down tests 848–852, look for stabilization before adding. Consider opportunistic partials into ~940 on strength per plan context, but primary targets remain unchanged.
Confidence 87%
11/01/2025 11:37 AM
Hold
gap_risk
near_term_resistance_870
elevated_rsi
sector_rotation_risk
competition_headline_risk
LLY closed at 862.60, sitting within the 848–865 entry band. Momentum remains constructive (MACD above signal, RSI ~67) and price is above short-term EMAs. No stop (840) or target (952–970) triggers and the 9-day horizon is intact. Maintain the position into next week. Watch 870 resistance on the next session; a strong break-and-hold could justify tightening the stop toward the 845–848 zone, but for now keep the explicit 840 hard stop to avoid premature shakeouts. Consider taking partials near ~940 on the way to targets to manage gap/event risk.
Confidence 87%
11/01/2025 10:39 AM
Tighten Stop
Stop Loss: 840
Overhead resistance near 870 may reject on next open
Weekend gap/news risk
Macro/sector rotation out of pharma
Competitive headlines (Novo) or supply constraints
Momentum fade risk if MACD rolls over or RSI cools
No stop/target/horizon triggers. Price remains within the entry band and momentum is constructive (RSI strong, MACD positive) with support above short-term EMAs. Expect some chop near ~870 resistance; maintain the plan but tighten risk below the 840 pivot to protect against weekend gap risk. Keep 952–970 targets and the 9-day horizon intact. Consider scaling small profits into ~940 if reached en route to targets.
Confidence 87%
11/01/2025 09:36 AM
Tighten Stop
Stop Loss: 830
weekend_gap_risk
near_term_resistance_~870
momentum_overbought_risk_rsi_>65
macro_rotation_risk
competition_risk_in_obesity_segment
supply_constraint_headline_risk
Setup remains intact. Last price 862.6 sits inside the 848–865 buy zone, momentum is constructive (RSI ~67, MACD positive), and no stop/target/horizon rules have triggered. Immediate resistance near 870 may cap the next attempt; weekend gap risk is present. Keep targets as-is and manage risk tighter given the strong post-earnings move. Consider trimming a starter around ~940 on strength en route to the 952–970 band.
Confidence 88%
11/01/2025 08:34 AM
Hold
weekend_headline_risk
macro_rotation_risk
competitive_risk_novo_nordisk
supply_constraint_risk
gap_risk_on_open
resistance_near_870
No rule triggers. Price (862.6) remains within the planned entry band (848–865) and well above the stop (820). Momentum/technicals remain constructive (RSI mid-60s, bullish MACD) and news flow is supportive. Maintain the original plan: respect 820 stop, target 952–970 over the 9-day window (expires 2025-11-09). Near-term resistance around ~870 and the prior high zone into the mid-930s could cause chop; per plan, consider partials near ~940 on strength, but no parameter changes now.
Confidence 90%
11/01/2025 07:34 AM
Hold
gap_risk_after_earnings
resistance_near_870
RSI_elevated
macro_rotation_risk
competition_headline_risk
supply_constraint_headline_risk
No rule trigger. Price 862.6 sits inside the 848–865 entry band, well above the 820 stop and below the 952–970 target zone. Momentum remains constructive (bullish MACD, RSI ~67) and the post-earnings news tone is positive. Immediate resistance remains ~870 (Friday high). Plan: maintain the current stop at 820 into next session; monitor 840/831 (support near EMA9) for health. A decisive breakout/close above ~870 would support tightening stops toward mid-840s on next review and managing a partial trim near ~940 en route to the 952–970 target band. Be mindful of weekend headline/gap risk into Monday.
Confidence 89%
11/01/2025 06:33 AM
Hold
near_term_resistance_870
rsi_elevated_65_plus
weekend_gap_risk
social_interest_cooling
macro_rotation_risk
competitor_actions_novo
supply_constraint_headline_risk
No rule triggered. Price 862.6 sits within the planned 848–865 entry zone; stop (820) and targets (952–970) untouched. Momentum remains constructive (RSI ~67, MACD > signal) with price above EMA9/21. Near-term resistance around 870; watch for early-week gap risk. Maintain the plan and monitor for follow-through toward prior highs; no change to targets or stop today.
Confidence 88%
10/31/2025 20:33 PM
Hold
post-earnings-volatility
weekend-gap-risk
resistance-near-870
macro-rotation-risk
competition-headline-risk
supply-constraint-risk
Price closed at 862.6, inside the planned 848–865 entry band, with bullish momentum (RSI ~66.7, positive MACD). No stop or target triggers and horizon is intact (day 0/9). Thesis remains supported by positive earnings/news flow. Expect near-term chop around 870 resistance; watch for Monday gap risk. Keep stop at 820 for now; consider taking partials near ~940 on the way to the 952–970 target if momentum stalls.
Confidence 88%
Related News